Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Patrignani

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Circulation|August 19, 1997
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable anginaF Cipollone, P Patrignani, A Greco, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Reumatismo|July 11, 2006
[Antinflammatory therapy and cardiovascular risk: a consensus view]D Gatti, S Adami, B Canesi, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Evidence for a renal origin of urinary thromboxane B2 in health and diseaseC Patrono, G Ciabattoni, P Patrignani, et al.
Clinical Pharmacology and Therapeutics|February 1, 2017
Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal CancerP Patrignani, A Sacco, C Sostres, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug actionP Patrignani, S Tacconelli, E Piazuelo, et al.
Circulation|August 2, 2000
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokersP Patrignani, M R Panara, S Tacconelli, et al.
Pharmacological Research|October 3, 2013
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunctionA Martelli, L Testai, M Anzini, et al.
Current Medicinal Chemistry|March 25, 2011
Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agentsM Biava, G C Porretta, G Poce, et al.
Reumatismo|October 8, 2004
[Italian consensus on Eular 2003 recommendations for the treatment of knee osteoarthritis]L Punzi, B Canesi, M Carrabba, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Circulation|August 19, 1997
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable anginaF Cipollone, P Patrignani, A Greco, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
Reumatismo|July 11, 2006
[Antinflammatory therapy and cardiovascular risk: a consensus view]D Gatti, S Adami, B Canesi, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1983
Evidence for a renal origin of urinary thromboxane B2 in health and diseaseC Patrono, G Ciabattoni, P Patrignani, et al.
Clinical Pharmacology and Therapeutics|February 1, 2017
Low-Dose Aspirin Acetylates Cyclooxygenase-1 in Human Colorectal Mucosa: Implications for the Chemoprevention of Colorectal CancerP Patrignani, A Sacco, C Sostres, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2014
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug actionP Patrignani, S Tacconelli, E Piazuelo, et al.
Circulation|August 2, 2000
Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokersP Patrignani, M R Panara, S Tacconelli, et al.
Pharmacological Research|October 3, 2013
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunctionA Martelli, L Testai, M Anzini, et al.
Current Medicinal Chemistry|March 25, 2011
Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agentsM Biava, G C Porretta, G Poce, et al.
Reumatismo|October 8, 2004
[Italian consensus on Eular 2003 recommendations for the treatment of knee osteoarthritis]L Punzi, B Canesi, M Carrabba, et al.
Pageof 8